Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Marzo

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Neurologia|July 26, 2019
Role of the gut microbiota in the development of various neurological diseasesF Castillo-Álvarez, M E Marzo-Sola
Neurologia|July 2, 2022
Role of the gut microbiota in the development of various neurological diseasesF Castillo-Álvarez, M E Marzo-Sola
Neurologia (Barcelona, Spain)|September 19, 2015
Role of intestinal microbiota in the development of multiple sclerosisF Castillo-Álvarez, M E Marzo-Sola
Studies in Health Technology and Informatics|June 30, 2023
Using Redcap to Support the Development of a Learning Healthcare System for Patients with Multiple SclerosisM Viguera, F Martin-Sanchez, M E Marzo
Revista Clinica Espanola|June 1, 1995
[Internuclear ophthalmoplegia in relation to lidocaine and pentothal]J R Ara, V Bertol, C Calderón, et al.
Revista De Neurologia|February 1, 1997
[Respiratory dyskinesia induced by veralipride]E Marta-Moreno, M Gracia-Naya, M E Marzo-Sola
Journal of Neurology, Neurosurgery, and Psychiatry|January 4, 1998
Recurrent Guillain-Barré syndrome and CNS demyelinationJ Río, C Nos, M Tintoré, et al.
Neurology|June 20, 1998
Low-dose steroids reduce flu-like symptoms at the initiation of IFNbeta-1b in relapsing-remitting MSJ Río, C Nos, M E Marzo, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 15, 1998
Chronic inflammatory demyelinating polyneuropathy during treatment with interferon-alphaM E Marzo, M Tintoré, O Fabregues, et al.
Neurologia (Barcelona, Spain)|January 12, 1999
[Profile of efficacy and safety in the treatment of remittent-recurrent multiple sclerosis with interferon beta-1b]J Río, M E Marzo, M Tintoré, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Neurologia|July 26, 2019
Role of the gut microbiota in the development of various neurological diseasesF Castillo-Álvarez, M E Marzo-Sola
Neurologia|July 2, 2022
Role of the gut microbiota in the development of various neurological diseasesF Castillo-Álvarez, M E Marzo-Sola
Neurologia (Barcelona, Spain)|September 19, 2015
Role of intestinal microbiota in the development of multiple sclerosisF Castillo-Álvarez, M E Marzo-Sola
Studies in Health Technology and Informatics|June 30, 2023
Using Redcap to Support the Development of a Learning Healthcare System for Patients with Multiple SclerosisM Viguera, F Martin-Sanchez, M E Marzo
Revista Clinica Espanola|June 1, 1995
[Internuclear ophthalmoplegia in relation to lidocaine and pentothal]J R Ara, V Bertol, C Calderón, et al.
Revista De Neurologia|February 1, 1997
[Respiratory dyskinesia induced by veralipride]E Marta-Moreno, M Gracia-Naya, M E Marzo-Sola
Journal of Neurology, Neurosurgery, and Psychiatry|January 4, 1998
Recurrent Guillain-Barré syndrome and CNS demyelinationJ Río, C Nos, M Tintoré, et al.
Neurology|June 20, 1998
Low-dose steroids reduce flu-like symptoms at the initiation of IFNbeta-1b in relapsing-remitting MSJ Río, C Nos, M E Marzo, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 15, 1998
Chronic inflammatory demyelinating polyneuropathy during treatment with interferon-alphaM E Marzo, M Tintoré, O Fabregues, et al.
Neurologia (Barcelona, Spain)|January 12, 1999
[Profile of efficacy and safety in the treatment of remittent-recurrent multiple sclerosis with interferon beta-1b]J Río, M E Marzo, M Tintoré, et al.
Pageof 3